Genexine Inc (095700) — Cash Flow Reinvestment Rate

Latest as of March 2025: 9.89x

Genexine Inc (095700) has a Cash Flow Reinvestment Rate of 9.89x as of March 2025, reinvesting ₩7.91 Billion (capex ₩3.89 Billion plus investments ₩-4.01 Billion) from operating cash flow of ₩799.82 Million. See 095700 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

9.89x
(Capex + Investments) / Operating CF

Total Reinvested

₩7.91 Billion
Capex + Investments

Operating Cash Flow

₩799.82 Million
KRW

Capital Expenditures

₩3.89 Billion
KRW

Genexine Inc Cash Flow Reinvestment Rate (2009–2012)

Historical reinvestment intensity for Genexine Inc across 2 annual periods. For the full cash flow conversion analysis, see Genexine Inc (095700) cash conversion ratio.

Annual Cash Flow Reinvestment Rate for Genexine Inc (2009–2012)

Year-by-year capital reinvestment analysis for Genexine Inc. See Genexine Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2012 12.61x ₩21.04 Billion ₩1.67 Billion ₩2.42 Billion ▼ -98.2%
2009 683.23x ₩24.07 Billion ₩35.23 Million ₩1.03 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow